Topotecan Weekly Versus Conventional 5-Day Schedule in Patients With Platinum-Resistant Ovarian Cancer: a randomized multicenter phase II trial of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group.
Related Research units
Abstract
Bibliographical data
Original language | English |
---|---|
Article number | 2 |
ISSN | 0732-183X |
DOIs | |
Publication status | Published - 10.01.2011 |